Capsaicin: Clinical Trials

20 trials of Capsaicin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 2 terminated, 1 recruiting, 1 unknown. 20 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 420Completed 15, Terminated 2, Recruiting 1, Unknown 1, Withdrawn 1

Follow Capsaicin: new trials by email Literature Review of Capsaicin trials Research Report on Capsaicin

Trials (filtered) newest first · largest first

All 20 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Capsaicin in Digital Osteoarthritis Versus Control
Capsaicin 179 Mg Cutaneous Patch, Capsaicine low dose 0.04 % - Osteoarthritis Hand, Neuropathic Pain
Phase 4RecruitingUniversity Hospital, Clermont-Ferrand1202025-03-072025-03-13
The Influence of Capsaicin Gel During Exercise Within the Heat
Capsaicin, Control Gel, Exercise - Acute Exercise, Heat Exposure
Phase 4CompletedUniversity of Nebraska122022-05-252024-03-15
Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome
Capsaicin, Placebo - Cannabinoid Hyperemesis Syndrome
Phase 4CompletedUniversity of Virginia202020-12-012024-10-18
Motor Unit Abnormalities After Experimentally Induced Sensitization
Capsaicin Topical Cream (0.075%), Delsys Trigno Galileo System, Excaliber, Natus Medical - Central Sensitisation, Motor Disorders
Phase 4CompletedToronto Rehabilitation Institute232019-10-012020-04-24
The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy
Lidocaine 5% patch, Capsaicin 8% Patch, Per 10 Square Centimeters - Diabetic Nerve Problems, Diabetic Neuropathy
Phase 4CompletedCorporacion Parc Tauli2902019-01-102020-01-30
Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment
Lidocaine patch 5%, Capsaicin 8% Patch, Pregabalin - Neuropathic Pain
Phase 4TerminatedUniversity Hospital, Antwerp332018-12-032021-04-28
Transdermal Delivery of Glucosamine to the Synovial Fluid of Male and Female With Knee Osteoarthritis
Transdermal Glucosamine Cream - Osteoarthritis, Knee
Phase 4CompletedLynk Biotechnologies Pte Ltd2402016-05-182018-11-16
Elaboration of Patient-friendly Treatment Strategy With Capsaicin Nasal Spray in Patients With Idiopathic Rhinitis
Capsaicin, placebo - Non-allergic Rhinitis
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven802015-07-012021-06-22
Pain Thresholds Under High-dose Topical Capsaicin
Topical High dose Capsaicin, Topical Placebo - Pain
Phase 4CompletedMedical University of Vienna202015-02-012015-10-07
Capsaicin on Salty Gustatory Cortices
Capsaicin, NaCl - Volunteers
Phase 4CompletedZhiming Zhu802013-05-012016-01-11
Qutenza for Critical Ischaemia in End Stage Renal Failure
QUTENZA - End Stage Renal Failure, Neuropathic Pain
Phase 4UnknownEmma Aitken202012-12-012012-10-11
A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment
Qutenza, Pregabalin - Non-diabetic Painful Peripheral Polyneuropathy, Postherpetic Neuralgia (PHN)
Phase 4CompletedAstellas Pharma Europe Ltd.5682012-07-112018-04-23
Mechanisms of Capsaicin Treatment in Idiopathic Rhinitis Patients and Controls
Capsaicin, diluent - Rhinitis
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven392012-02-012014-12-05
Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch
QUTENZA, Lidocaine, Tramadol - or Peripheral Nerve Injury (PNI), Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN)
Phase 4CompletedAstellas Pharma Inc1222011-07-062018-04-23
Neuro-immunological Analysis of Idiopathic Rhinitis Patients and Controls Treated With Capsaicin.
Capsaicin - Idiopathic Rhinitis Patients, Healthy Controls
Phase 4CompletedUniversitaire Ziekenhuizen KU Leuven362011-01-012011-10-03
Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage
QUTENZA - Neuralgia, Postherpetic
Phase 4CompletedAstellas Pharma Inc3062010-10-282018-04-19
Cervical Capsaicin for Labor Induction and Pain Relief
capsaicin, Placebo - Labor Pain, Pregnancy Loss
Phase 4WithdrawnColumbia University2010-10-012021-08-09
Ethnic Differences in Response to Topical Capsaicin: A Psychophysical Study on Healthy Subjects
Capsaicin, Placebo moisturizing cream - Healthy
Phase 4CompletedWake Forest University402008-02-012018-09-10
Effects of Capsaicin on the Structure, Distribution, and Function of Cutaneous Small Nerve Fibers in Psoriatic Skin
Capsaicin - Psoriasis
Phase 4TerminatedWake Forest University122006-06-012018-08-13
Response of Topical Capsaicin in Alopecia Areata
Capsaicin - Alopecia Areata
Phase 4CompletedUniversity of Minnesota241997-08-012014-06-02

Conditions studied

Neuralgia (3)  ·  Neuralgia, Postherpetic (2)  ·  Peripheral Nerve Injuries (2)  ·  Alopecia Areata (1)  ·  Cannabinoid Hyperemesis Syndrome (1)  ·  Common Cold (1)  ·  Diabetic Neuropathies (1)  ·  Labor Pain (1)  ·  Motor Activity (1)  ·  Motor Disorders (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)  ·  Pain (1)  ·  Psoriasis (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Universitaire Ziekenhuizen KU Leuven (3)  ·  Astellas Pharma Inc (2)  ·  Wake Forest University (2)  ·  Astellas Pharma Europe Ltd. (1)  ·  Columbia University (1)  ·  Corporacion Parc Tauli (1)  ·  Emma Aitken (1)  ·  Lynk Biotechnologies Pte Ltd (1)  ·  Medical University of Vienna (1)  ·  Toronto Rehabilitation Institute (1)  ·  University Hospital, Antwerp (1)  ·  University Hospital, Clermont-Ferrand (1)  ·  University of Minnesota (1)  ·  University of Nebraska (1)  ·  University of Virginia (1)

Countries

Belgium (7)  ·  United States (5)  ·  United Kingdom (4)  ·  Austria (3)  ·  Czechia (3)  ·  France (3)  ·  Slovakia (3)  ·  Finland (2)  ·  Greece (2)  ·  Hungary (2)  ·  Ireland (2)  ·  Italy (2)  ·  Poland (2)  ·  Romania (2)  ·  Slovenia (2)

Top investigators

Gil Yosipovitch, MD (2)  ·  Angela Holian, PharmD (1)  ·  Choon Meng Ting, MD (1)  ·  Dinesh Kumbahre, PhD (1)  ·  Dustin R Slivka, PHD (1)  ·  Emma L Aitken, MBChB (1)  ·  Erich Knolle, MD (1)  ·  Guy Hans, MD, PhD (1)  ·  Laura H Van Gerven, MD (1)  ·  Laura Van Gerven, Doctor (1)  ·  Maria Hordinsky, MD (1)  ·  Marna Ericson, Ph D (1)  ·  Pamela Flood, MD (1)  ·  Peter Hellings, Doctor (1)

Results publications

PMID 32439432, PMID 34215800, PMID 34554688, PMID 36729473, PMID 37089721, PMID 40050054

NIH funding

2009 (1)